Open links in new tab
  1. Menactra (Vaccine): Uses, Dosage & Side Effects - Drugs.com

    • Menactra is used to prevent infection caused by serogroups A, C, W, and Y. This vaccine helps your body develop immunity to meningitis. Meningococcal vaccine will not treat an active meningococcal inf… See more

    Warnings

    You should not receive Menactra if you have ever had an allergic reaction to a meningococcal or diphtheria vaccine. You should not receive a booster vaccine if you had a life th… See more

    Drugs.com
    Before Taking This Medicine

    You may not be able to receive Menactra if you've ever had an allergic reaction to a … See more

    Drugs.com
    How Is Menactra given?

    Menactra is given as an injection (shot) into a muscle. You will receive this injection in a doctor's office or clinic setting. Menactra is recommended if: 1. you've been exposed to an outbrea… See more

    Drugs.com
    Dosing Information

    Menactra is given as a 0.5ml dose by intramuscular injection. Do not administer Menactra intravenously or subcutaneously. Primary Vaccination: 1. In children 9 through 23 … See more

    Drugs.com
    What Happens If I Miss A dose?

    Contact your vaccination provider if you miss a booster dose or if you get behind schedule. The next dose should be given as soon as possible. There is no need to start over.… See more

    Drugs.com
    Feedback
     
  1. Menactra | FDA - U.S. Food and Drug Administration

  2. Meningococcal Vaccine Administration | CDC

  3. Meningococcal Vaccine Recommendations - CDC

    October 24, 2024. Meningococcal Vaccine Recommendations. Key points. CDC recommends meningococcal vaccination for all adolescents. CDC also recommends meningococcal vaccination for children and adults at increased …

  4. Meningococcal Vaccination | Meningococcal | CDC

  5. Menactra: Package Insert / Prescribing Info - Drugs.com

    Jan 15, 2023 · Menactra is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra is approved for use in individuals 9 months through 55 …

  6. ACIP Updates Recommendations for Meningococcal …

    Oct 7, 2020 · Three MenACWY vaccines are licensed for use in the United States: Menactra (for persons age 9 months to 55 years), Menveo (for those age 2 months to 55 years) and MenQuadfi (for those age 2...

  7. Menactra, Menveo (meningococcal A C Y and W-135) …

    Meningococcal Vaccination. Indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals. 0.5 mL/dose...

  8. Meningococcal Meningitis (MenACWY) Vaccine | MenQuadfi® …

  9. Menactra (Intramuscular) - Drugs.com

  10. Some results have been removed